DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 61 filers reported holding DESIGN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7 | -12.5% | 2,026 | 0.0% | 0.00% | – |
| Q1 2024 | $8 | +60.0% | 2,026 | 0.0% | 0.00% | – |
| Q4 2023 | $5 | 0.0% | 2,026 | -3.1% | 0.00% | – |
| Q3 2023 | $5 | -61.5% | 2,090 | +4.8% | 0.00% | – |
| Q2 2023 | $13 | -87.3% | 1,994 | -88.7% | 0.00% | – |
| Q1 2023 | $102 | -59.4% | 17,634 | -27.9% | 0.00% | – |
| Q4 2022 | $251 | -99.9% | 24,466 | +0.9% | 0.00% | -100.0% |
| Q3 2022 | $405,000 | +32.8% | 24,246 | +11.1% | 0.00% | – |
| Q2 2022 | $305,000 | -13.6% | 21,814 | -0.3% | 0.00% | – |
| Q1 2022 | $353,000 | +27.4% | 21,876 | +68.8% | 0.00% | – |
| Q4 2021 | $277,000 | +61.0% | 12,957 | +10.4% | 0.00% | – |
| Q3 2021 | $172,000 | -25.5% | 11,738 | +1.2% | 0.00% | – |
| Q2 2021 | $231,000 | – | 11,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 6,526,476 | $66,961,644 | 24.44% |
| Cormorant Asset Management, LP | 5,150,000 | $52,839 | 3.54% |
| Logos Global Management LP | 2,797,501 | $28,702,360 | 3.36% |
| RA Capital Management | 2,971,231 | $30,484,830 | 0.62% |
| Ghost Tree Capital, LLC | 82,853 | $850,000 | 0.36% |
| Avoro Capital Advisors LLC | 2,272,222 | $23,312,998 | 0.35% |
| EcoR1 Capital, LLC | 884,903 | $9,079,105 | 0.28% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 57,025 | $585,077 | 0.17% |
| Ikarian Capital, LLC | 48,500 | $497,610 | 0.12% |
| Rock Springs Capital Management LP | 460,391 | $4,723,612 | 0.11% |